Journal of Immunotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.9 | Q3 | 48.2% | 1.088 | Q1 | 86.0% |
| 2024 | 2.9 | Q2 | 53.4% | 1.203 | Q1 | 88.5% |
| 2023 | 3.2 | Q2 | 57.1% | 1.263 | Q1 | 90.2% |
| 2022 | 3.9 | Q2 | 59.4% | 1.397 | Q1 | 92.2% |
| 2021 | 4.9 | Q2 | 66.0% | 1.182 | Q1 | 89.7% |
| 2020 | — | — | 1.805 | Q1 | 94.6% | |
| 2019 | — | — | 1.557 | Q1 | 93.1% | |
| 2018 | — | — | 1.568 | Q1 | 92.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1537-4513
ISSN
1524-9557
country
UScoverage
1991-2026